Lv41
510 积分 2025-07-24 加入
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
1个月前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
1个月前
已完结
Bioactive enhanced adjuvant chemokine oligonucleotide nanoparticles (BEACONs) for mucosal vaccination against genital herpes
3个月前
已完结
Characterization and Comparison of Two NPC Cell Lines, C17 and C666-1, as Models for Studying the Pathogenesis of Nasopharyngeal Carcinoma
5个月前
已完结
Immunity, tolerance and autoimmunity in the liver: A comprehensive review
5个月前
已完结
Immune Responses in the Liver
5个月前
已完结
Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications
5个月前
已完结
Harnessing alternative splicing for off-the-shelf mRNA neoantigen vaccines in hepatocellular carcinoma
6个月前
已完结
EBNA1 Targeted Ultra‐Small Near‐Infrared Persistent Luminescent Nano‐Inhibitor for Theranostics of EBV‐Associated Cancer
6个月前
已完结
Establishment of a cell line (NPC/HK1) from a differentiated squamous carcinoma of the nasopharynx
6个月前
已完结
皖公网安备34019202002308
